Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Manuel J. Barbanoj

Plasma and Intracellular (Peripheral Blood Mononuclear Cells) Pharmacokinetics of Once-Daily Raltegravir (800 Milligrams) in HIV-Infected Patients

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2010

English

Related publications

Plasma and Intracellular Pharmacokinetics of Darunavir/Ritonavir Once Daily and Raltegravir Once and Twice Daily in HIV-Infected Individuals

Journal of Acquired Immune Deficiency Syndromes

Infectious Diseases

Pharmacology

2011

English

Proteomic Analysis of Human Plasma and Peripheral Blood Mononuclear Cells in Systemic Lupus Erythematosus Patients

Journal of Immunological Methods

Allergy

Immunology

2017

English

Upregulation of Human Immunodeficiency Virus (HIV) Replication by CD4 Cross-Linking in Peripheral Blood Mononuclear Cells of HIV-infected Adults.

English

Raltegravir for HIV-1 Infected Children and Adolescents: Efficacy, Safety, and Pharmacokinetics

Adolescent Health, Medicine and Therapeutics

2013

English

microRNA Expression Profiling and Bioinformatic Analysis of Dengue Virus‑infected Peripheral Blood Mononuclear Cells

Molecular Medicine Reports

English

Pharmacokinetics and Acceptability of Once- Versus Twice-Daily Lamivudine and Abacavir in HIV Type-1-Infected Ugandan Children in the ARROW Trial

English

Why Are the Neurodegenerative Disease-Related Pathways Overrepresented in Primary HIV-infected Peripheral Blood Mononuclear Cells: A Genome-Wide Perspective

English

Impact of UGT1A1 Polymorphisms on Raltegravir and Its Glucuronide Plasma Concentrations in a Cohort of HIV-1 Infected Patients

Scientific Reports

Multidisciplinary

2018

English

Effect of HIV-infection and Menopause Status on Raltegravir Pharmacokinetics in the Blood and Genital Tract

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Manuel J. Barbanoj

Plasma and Intracellular (Peripheral Blood Mononuclear Cells) Pharmacokinetics of Once-Daily Raltegravir (800 Milligrams) in HIV-Infected Patients

Related publications

Plasma and Intracellular Pharmacokinetics of Darunavir/Ritonavir Once Daily and Raltegravir Once and Twice Daily in HIV-Infected Individuals

Proteomic Analysis of Human Plasma and Peripheral Blood Mononuclear Cells in Systemic Lupus Erythematosus Patients

Upregulation of Human Immunodeficiency Virus (HIV) Replication by CD4 Cross-Linking in Peripheral Blood Mononuclear Cells of HIV-infected Adults.

Raltegravir for HIV-1 Infected Children and Adolescents: Efficacy, Safety, and Pharmacokinetics

microRNA Expression Profiling and Bioinformatic Analysis of Dengue Virus‑infected Peripheral Blood Mononuclear Cells

Pharmacokinetics and Acceptability of Once- Versus Twice-Daily Lamivudine and Abacavir in HIV Type-1-Infected Ugandan Children in the ARROW Trial

Why Are the Neurodegenerative Disease-Related Pathways Overrepresented in Primary HIV-infected Peripheral Blood Mononuclear Cells: A Genome-Wide Perspective

Impact of UGT1A1 Polymorphisms on Raltegravir and Its Glucuronide Plasma Concentrations in a Cohort of HIV-1 Infected Patients

Effect of HIV-infection and Menopause Status on Raltegravir Pharmacokinetics in the Blood and Genital Tract